Shulin Wei
Luzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Liuweizhiji Gegen-Sangshen beverage protects against alcoholic liver disease in mice through the gut microbiota mediated SCFAs/GPR43/GLP-1 pathway.
Journal: Frontiers in nutrition
Published: September 13, 2024
Gegen-Sangshen oral liquid and its active fractions mitigate alcoholic liver disease in mice through repairing intestinal epithelial injury and regulating gut microbiota.
Journal: Chinese medicine
Published: September 04, 2024
Organoid, organ-on-a-chip and traditional Chinese medicine.
Journal: Chinese medicine
Published: July 24, 2024
Fingerprint profiling for quality evaluation and the related biological activity analysis of polysaccharides from Liuweizhiji Gegen-Sangshen beverage.
Journal: Frontiers in nutrition
Published: May 12, 2024
Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease.
Journal: Journal of inflammation research
Published: January 04, 2024
Rosavin derived from Rhodiola alleviates colitis in mice through modulation of Th17 differentiation.
Rosavin derived from Rhodiola alleviates colitis in mice through modulation of Th17 differentiation.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 25, 2023
Chemical profiling and quality evaluation of Liuweizhiji Gegen-Sangshen oral liquid by UPLC-Q-TOF-MS and HPLC-diode array detector fingerprinting.
Journal: Phytochemical analysis : PCA
Published: November 13, 2023
Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases.
Journal: Journal of pharmaceutical analysis
Published: February 10, 2023
Chinese herbal medicines for treating ulcerative colitis via regulating gut microbiota-intestinal immunity axis.
Journal: Chinese herbal medicines
Published: October 07, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026